Medpace Holdings, Inc. Class Action Lawsuit
Company: Medpace Holdings, Inc.
Ticker: (NASDAQ) MEDP
Class Action Period: April 22, 2025 - February 9, 2026
See If You Qualify For Monetary Reward
Join the Medpace Holdings, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
April 22, 2025 - February 9, 2026
Allegations
According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the true state of Medpace's backlog cancellation rate. Defendants continuously touted "well behaved" cancellation rates. Furthermore, Medpace made clear that cancellations were not caused by weak business or a weak funding environment, providing investors with overly positive growth expectations that could not maintain the projected 1.15 book-to-bill ratio. On February 9, 2026, Medpace issued a press release announcing the Company's fourth quarter 2025 book-to-bill ratio of 1.04, well below the guidance of 1. 15. Following this news, the price of Medpace's common stock declined dramatically. From a closing market price of $530.35 per share on February 9, 2026, Medpace's common stock price fell to $446. 05 per share on February 10, 2026, a decline of more than 15.9%.
Eligibility
To join the lawsuit, you must have experienced a loss on Medpace Holdings, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Medpace Holdings, Inc. during the relevant time frame, you have until June 8, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against Medpace Holdings, Inc. (NASDAQ: MEDP)?
Investors who purchased shares of Medpace Holdings, Inc. (NASDAQ: MEDP) during the class period (April 22, 2025 - February 9, 2026) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is June 8, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the Medpace Holdings, Inc. lawsuit?
Anyone who bought shares of Medpace Holdings, Inc. (NASDAQ: MEDP) during April 22, 2025 - February 9, 2026 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the Medpace Holdings, Inc. case?
The lead plaintiff deadline for the Medpace Holdings, Inc. lawsuit is June 8, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for Medpace Holdings, Inc.?
The class period for Medpace Holdings, Inc. (NASDAQ: MEDP) is April 22, 2025 - February 9, 2026, during which investors may have been affected by alleged misconduct.
- Can I still join the Medpace Holdings, Inc. lawsuit if I sold my shares?
Yes. Investors who purchased Medpace Holdings, Inc. shares during April 22, 2025 - February 9, 2026 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Medpace Holdings, Inc. lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Medpace Holdings, Inc. case may receive a portion of the recovery.
- Do I need to pay to participate in the Medpace Holdings, Inc. case?
No, most securities fraud cases involving Medpace Holdings, Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the Medpace Holdings, Inc. lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Medpace Holdings, Inc. case on behalf of participants.
- What documents are required for the Medpace Holdings, Inc. lawsuit?
To participate in the Medpace Holdings, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Medpace Holdings, Inc.?
After submission, your details for the Medpace Holdings, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Medpace Holdings, Inc. lawsuit?
No, this page provides information about the Medpace Holdings, Inc. case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Medpace Holdings, Inc. case?
The lead plaintiff deadline for the Medpace Holdings, Inc. lawsuit is June 8, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Apollo Global management, Inc.
APO
Lead Plaintiff Deadline: May 1, 2026
Class Period: May 10, 2021 - February 21, 2026
Kyndryl Holdings, Inc.
KD
Lead Plaintiff Deadline: April 13, 2026
Class Period: August 1, 2024 - February 9, 2026